BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3909466)

  • 1. [Clinical aspects of platelet transfusion].
    Julia A; Massuet L; Pujol M; Martín Vega C
    Sangre (Barc); 1985; 30(4-B):548-56. PubMed ID: 3909466
    [No Abstract]   [Full Text] [Related]  

  • 2. The transfusion of HLA-matched platelets to thrombocytopenic patients resistant to random donor platelets.
    Levy L; Woodfield DG
    N Z Med J; 1984 Oct; 97(766):719-21. PubMed ID: 6595558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Transfusion of platelet concentrates].
    Rieux C; Lee K; Lavaud A; Bierling P
    Ann Med Interne (Paris); 1999 Dec; 150(8):631-41. PubMed ID: 10686645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical aspects of thrombocyte transfusion].
    Kummer H
    Beitr Infusionther Klin Ernahr; 1986; 15():156-64. PubMed ID: 3753407
    [No Abstract]   [Full Text] [Related]  

  • 5. Platelet transfusion refractoriness.
    Hod E; Schwartz J
    Br J Haematol; 2008 Jul; 142(3):348-60. PubMed ID: 18510692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet transfusions to HLA-immunized recipients: how to be or not to be matched.
    Rubinstein P
    Transfusion; 2010 Nov; 50(11):2292-4. PubMed ID: 21182628
    [No Abstract]   [Full Text] [Related]  

  • 7. [Platelet transfusion].
    Mannoni P; Rodet M; Beaujean F
    Rev Fr Transfus Immunohematol; 1976 Sep; 19(3):489-511. PubMed ID: 1006056
    [No Abstract]   [Full Text] [Related]  

  • 8. Background, rationale, and design of a clinical trial to assess the effects of platelet dose on bleeding risk in thrombocytopenic patients.
    Slichter SJ
    J Clin Apher; 2006 Apr; 21(1):78-84. PubMed ID: 16619231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Platelet pool versus single platelet donor].
    Rev Fr Transfus Immunohematol; 1987 Nov; 30(4):293-319. PubMed ID: 2832927
    [No Abstract]   [Full Text] [Related]  

  • 10. A therapeutic platelet transfusion strategy is safe and feasible in patients after autologous peripheral blood stem cell transplantation.
    Wandt H; Schaefer-Eckart K; Frank M; Birkmann J; Wilhelm M
    Bone Marrow Transplant; 2006 Feb; 37(4):387-92. PubMed ID: 16400342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donor availability for platelet transfusion support of alloimmunized thrombocytopenic patients.
    Duquesnoy RJ; Vieira J; Aster RH
    Transplant Proc; 1977 Mar; 9(1):519-21. PubMed ID: 867500
    [No Abstract]   [Full Text] [Related]  

  • 12. Bleeding risk and platelet transfusion refractoriness in patients with acute myelogenous leukemia who undergo autologous stem cell transplantation.
    Toor AA; Choo SY; Little JA
    Bone Marrow Transplant; 2000 Aug; 26(3):315-20. PubMed ID: 10967572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Thrombocyte substitution in children under cytostatic therapy].
    Wernet D; Schnaidt M; Klingebiel T; Schneider W
    Beitr Infusionther Klin Ernahr; 1986; 15():172-8. PubMed ID: 3463300
    [No Abstract]   [Full Text] [Related]  

  • 14. Platelet transfusion prophylaxis for patients with haematological malignancies: where to now?
    Stanworth SJ; Hyde C; Brunskill S; Murphy MF
    Br J Haematol; 2005 Dec; 131(5):588-95. PubMed ID: 16351634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Thrombocyte substitution. I. Indications and clinical use of thrombocyte transfusion].
    Anders O; Preussner S; Konrad H
    Z Gesamte Inn Med; 1986 Nov; 41(21):592-5. PubMed ID: 3825211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of a freshly prepared thrombocyte mass in thrombocytopenic hemorrhages].
    Baĭdurin SA
    Probl Gematol Pereliv Krovi; 1980 Mar; 25(3):33-9. PubMed ID: 7367409
    [No Abstract]   [Full Text] [Related]  

  • 17. [Application of platelet transfusion and their problems].
    Ryo R; Hashimoto M; Takada S; Goto M; Yamaguchi N
    Nihon Naika Gakkai Zasshi; 1993 Jul; 82(7):1047-52. PubMed ID: 8228483
    [No Abstract]   [Full Text] [Related]  

  • 18. Refractory thrombocytopenia and positive platelet crossmatches without HLA or platelet-specific antibodies.
    Kankirawatana S; Huang ST; Arndt DW; Marques MB
    Am J Hematol; 2007 Feb; 82(2):175-6. PubMed ID: 16924652
    [No Abstract]   [Full Text] [Related]  

  • 19. Transfusion of platelets and plasma products.
    Menitove JE; Aster RH
    Clin Haematol; 1983 Feb; 12(1):239-66. PubMed ID: 6340882
    [No Abstract]   [Full Text] [Related]  

  • 20. Neonatal alloimmune thrombocytopenia due to anti-human leukocyte antigen antibody: a case report.
    Sasaki M; Yagihashi A; Kobayashi D; Watanabe N; Fujikawa T; Chiba S; Sato S; Morishita K; Sekimoto T; Ikeda H
    Pediatr Hematol Oncol; 2001 Dec; 18(8):519-24. PubMed ID: 11764101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.